Works matching AU Inoue, Masanori

Results: 65
    1

    Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2025, v. 55, n. 5, p. 718, doi. 10.1111/hepr.14160
    By:
    • Yonemoto, Takuya;
    • Ogasawara, Sadahisa;
    • Kanogawa, Naoya;
    • Miwa, Chihiro;
    • Fujiya, Makoto;
    • Tsuchiya, Takahiro;
    • Sawada, Midori;
    • Akatsuka, Teppei;
    • Izai, Ryo;
    • Yumita, Sae;
    • Nakagawa, Miyuki;
    • Okubo, Tomomi;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Nakamoto, Shingo;
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Itobayashi, Ei
    Publication type:
    Article
    2

    Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma.

    Published in:
    JGH Open, 2021, v. 5, n. 2, p. 273, doi. 10.1002/jgh3.12483
    By:
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Ooka, Yoshihiko;
    • Inoue, Masanori;
    • Wakamatsu, Toru;
    • Yokoyama, Masayuki;
    • Maruta, Susumu;
    • Unozawa, Hidemi;
    • Iwanaga, Terunao;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Maeda, Takahiro;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kondo, Takayuki;
    • Saito, Tomoko;
    • Motoyama, Tenyu
    Publication type:
    Article
    3
    4
    5

    Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis.

    Published in:
    Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 513, doi. 10.1007/s40801-023-00379-x
    By:
    • Kanzaki, Hiroaki;
    • Ogasawara, Sadahisa;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Yoshino, Ryohei;
    • Fujimoto, Kentaro;
    • Kogure, Tadayoshi;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Iwanaga, Terunao;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Kojima, Ryuta;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kanogawa, Naoya;
    • Kiyono, Soichiro;
    • Nakamura, Masato
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma.

    Published in:
    BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02674-x
    By:
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Maruta, Susumu;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Yumita, Sae;
    • Iwanaga, Terunao;
    • Unozawa, Hidemi;
    • Nakagawa, Miyuki;
    • Fujiwara, Kisako;
    • Sakuma, Takafumi;
    • Fujita, Naoto;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Kobayashi, Kazufumi;
    • Inoue, Masanori;
    • Kiyono, Soichiro
    Publication type:
    Article
    13
    14
    15
    16
    17

    Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage‐associated molecular pattern analysis.

    Published in:
    Hepatology Research, 2025, v. 55, n. 2, p. 291, doi. 10.1111/hepr.14088
    By:
    • Ozaki, Tomomi;
    • Yumita, Sae;
    • Ogasawara, Sadahisa;
    • Fujiya, Makoto;
    • Tsuchiya, Takahiro;
    • Yoshino, Ryohei;
    • Sawada, Midori;
    • Akatsuka, Teppei;
    • Izai, Ryo;
    • Miwa, Chihiro;
    • Yonemoto, Takuya;
    • Fujimoto, Kentaro;
    • Unozawa, Hidemi;
    • Fujiwara, Kisako;
    • Kojima, Ryuta;
    • Kanzaki, Hiroaki;
    • Koroki, Keisuke;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Nakamura, Masato
    Publication type:
    Article
    18

    Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41425-6
    By:
    • Kondo, Takayuki;
    • Fujimoto, Kentaro;
    • Fujiwara, Kisako;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Nakagawa, Miyuki;
    • Iwanaga, Terunao;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Kato, Jun;
    • Fujiwara, Keiichi
    Publication type:
    Article
    19

    Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41425-6
    By:
    • Kondo, Takayuki;
    • Fujimoto, Kentaro;
    • Fujiwara, Kisako;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Nakagawa, Miyuki;
    • Iwanaga, Terunao;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Kato, Jun;
    • Fujiwara, Keiichi
    Publication type:
    Article
    20

    Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38377-2
    By:
    • Kondo, Takayuki;
    • Fujiwara, Kisako;
    • Nakagawa, Miyuki;
    • Fujimoto, Kentaro;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Iwanaga, Terunao;
    • Koroki, Keisuke;
    • Kanzaki, Hiroaki;
    • Inoue, Masanori;
    • Kobayashi, Kazufumi;
    • Kiyono, Soichiro;
    • Nakamura, Masato;
    • Kanogawa, Naoya;
    • Ogasawara, Sadahisa;
    • Nakamoto, Shingo;
    • Chiba, Tetsuhiro;
    • Kato, Jun;
    • Kato, Naoya
    Publication type:
    Article
    21

    Acute myeloid leukemia associated with CHARGE syndrome.

    Published in:
    American Journal of Medical Genetics. Part A, 2023, v. 191, n. 3, p. 878, doi. 10.1002/ajmg.a.63087
    By:
    • Shuto, Marie;
    • Hirano, Naoki;
    • Oguri, Saori;
    • Itonaga, Tomoyo;
    • Inoue, Masanori;
    • Suenobu, Souichi;
    • Ihara, Kenji
    Publication type:
    Article
    22
    23
    24
    25

    Japanese clinical practice guidelines for vascular anomalies 2017.

    Published in:
    Pediatrics International, 2020, v. 62, n. 3, p. 257, doi. 10.1111/ped.14077
    By:
    • Mimura, Hidefumi;
    • Akita, Sadanori;
    • Fujino, Akihiro;
    • Jinnin, Masatoshi;
    • Ozaki, Mine;
    • Osuga, Keigo;
    • Nakaoka, Hiroki;
    • Morii, Eiichi;
    • Kuramochi, Akira;
    • Aoki, Yoko;
    • Arai, Yasunori;
    • Aramaki, Noriko;
    • Inoue, Masanori;
    • Iwashina, Yuki;
    • Iwanaka, Tadashi;
    • Ueno, Shigeru;
    • Umezawa, Akihiro;
    • Ozeki, Michio;
    • Ochi, Junko;
    • Kinoshita, Yoshiaki
    Publication type:
    Article
    26

    Combination therapy of ecabet sodium and cimetidine compared with cimetidine alone for gastric ulcer: Prospective randomized multicenter study.

    Published in:
    Journal of Gastroenterology & Hepatology, 2003, v. 18, n. 9, p. 1029, doi. 10.1046/j.1440-1746.2003.03093.x
    By:
    • MURATA, HIROAKI;
    • KAWANO, SUNAO;
    • TSUJI, SHINGO;
    • KAMADA, TAKENOBU;
    • MATSUZAWA, YUUJI;
    • KATSU, KENICHI;
    • INOUE, KYOUICHI;
    • KOBAYASHI, KENICHI;
    • MITSUFUJI, SYOUJI;
    • BAMBA, TADAO;
    • KAWASAKI, HIRONAKA;
    • KAJIYAMA, GOROU;
    • UMEGAKI, EIJI;
    • INOUE, MASANORI;
    • SAITO, ICHIMONJI
    Publication type:
    Article
    27
    28
    29
    30
    31

    Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 4, p. 590, doi. 10.1002/cncr.34559
    By:
    • Nakagawa, Miyuki;
    • Inoue, Masanori;
    • Ogasawara, Sadahisa;
    • Maruta, Susumu;
    • Okubo, Tomomi;
    • Itokawa, Norio;
    • Iino, Yotaro;
    • Obu, Masamichi;
    • Haga, Yuki;
    • Seki, Atsuyoshi;
    • Kikuchi, Yasuharu;
    • Kogure, Tadayoshi;
    • Yumita, Sae;
    • Ishino, Takamasa;
    • Ogawa, Keita;
    • Fujiwara, Kisako;
    • Iwanaga, Terunao;
    • Fujita, Naoto;
    • Sakuma, Takafumi;
    • Kojima, Ryuta
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39

    Management of Eyelid Sebaceous Carcinomas.

    Published in:
    Ophthalmologica, 1997, v. 211, n. 1, p. 40, doi. 10.1159/000310872
    By:
    • Dogru, Murat;
    • Matsuo, Hirofumi;
    • Inoue, Masanori;
    • Okubo, Kiyoshi;
    • Yamamoto, Misao
    Publication type:
    Article
    40

    Eccrine Adenocarcinoma of the Lacrimal Sac Region.

    Published in:
    Ophthalmologica, 1997, v. 211, n. 1, p. 44, doi. 10.1159/000310873
    By:
    • Karim, Mohammed Mohibul;
    • Inoue, Masanori;
    • Minato, Kazumi;
    • Yamamoto, Misao;
    • Kanomata, Naoki;
    • Ohbayashi, Chiho;
    • Ito, Hiroshi
    Publication type:
    Article
    41

    Japanese clinical practice guidelines for vascular anomalies 2017.

    Published in:
    2020
    By:
    • Mimura, Hidefumi;
    • Akita, Sadanori;
    • Fujino, Akihiro;
    • Jinnin, Masatoshi;
    • Ozaki, Mine;
    • Osuga, Keigo;
    • Nakaoka, Hiroki;
    • Morii, Eiichi;
    • Kuramochi, Akira;
    • Aoki, Yoko;
    • Arai, Yasunori;
    • Aramaki, Noriko;
    • Inoue, Masanori;
    • Iwashina, Yuki;
    • Iwanaka, Tadashi;
    • Ueno, Shigeru;
    • Umezawa, Akihiro;
    • Ozeki, Michio;
    • Ochi, Junko;
    • Kinoshita, Yoshiaki
    Publication type:
    journal article
    42
    43
    44
    45
    46
    47
    48
    49
    50